Substance Use Disorders

The American College of Obstetricians and Gynecologists has identified the following resources that may be helpful for ob-gyns, other health care providers and patients on topics related to substance use disorders during pregnancy. 

These materials are for information purposes only and are not meant to be comprehensive. Referral to these resources does not imply ACOG's endorsement of the organization, the organization’s website, or the content of the resource. The resources may change without notice.


Jump to

Guidance and Resources for Providers
Resources for Patients and Families
Advocacy Resources


Guidance and Resources for Providers

Alcohol Abuse and Other Substance Use Disorders: Ethical Issues in Obstetric and Gynecologic Practice (Committee Opinion No. 633, June 2015)


Webinar

 

 

Webinar recording: ASAM:ACOG Buprenorphine Waiver Training Information Session

Webinar


 

 

Webinar recording: 

Coding for Substance Use: Opioid Use, Alcohol Use, Tobacco Use

Guidelines for Perinatal Care, 8th Edition (2017)

Marijuana Use During Pregnancy and Lactation (Committee Opinion No. 722, Oct. 2017)

Methamphetamine Abuse in Women of Reproductive Age (Committee Opinion No. 479, March 2011, Reaffirmed 2017)

Opioid Use and Opioid Use Disorder in Pregnancy (Committee Opinion No. 711, August 2017)

Performance Enhancing Anabolic Steroid Abuse in Women (Committee Opinion No. 484, April 2011, Reaffirmed 2018)

Postpartum Pain Management (Committee Opinion No. 742, July 2018 and Resource Overview)

Practice Advisory: FDA Boxed Warning on Immediate-Release Opioid Medications and All Prescription Opioids (March 2016)

Screening Tools, Behavioral Therapy, and Medications for Substance Use and Opioid Use Disorder

Substance Abuse Reporting and Pregnancy: The Role of the Obstetrician-Gynecologist  (Committee Opinion No. 473, January 2011, Reaffirmed 2014)

Substance use disorders in pregnancy: clinical, ethical, and research imperatives of the opioid epidemic: a report of a joint workshop of the SMFM, ACOG, and ASAM


Resources for Patients and Families

Marijuana Use During Pregnancy Infographic

Opioid Use Disorder and Pregnancy (Infographic, September 2018)

Opioid Use Disorder and Pregnancy Frequently Asked Questions (open access) (FAQ 506, September 2018)

Tobacco, Alcohol, Drugs and Pregnancy: FAQ SheetFrequently Asked Questions (open access) (FAQ 170, December 2017), Patient Education Pamphlet for purchaseSpanish Patient Education Pamphlet (open access)

 

Advocacy Resources

Addressing the Opioid Epidemic describes the principles adopted by six organizations representing front-line physicians to address the opioid crisis. Organizations include the American Academy of Family Physicians, American Academy of Pediatrics, American College of Obstetricians and Gynecologists, American College of Physicians, American Osteopathic Association, and American Psychiatric Association

American Medical Association’s (AMA) Opioid Task Force. Read ACOG's Statement on Opioid Abuse (July 2015)Help save lives: Co-prescribe naloxone to patients at risk of overdose. American Medical Association Opioid Task Force (Supported September 2017)│AMA and ACOG one pager on Removing Barriers to Medication-Assisted Treatment (MAT) for Substance Use DisorderLearn more about AMA’s Task Force

Opioid Use in Pregnancy, Neonatal Abstinence Syndrome, and Childhood Outcomes: Executive Summary of a Joint Workshop by the Eunice Kennedy Shriver National Institute of Child Health and Human Development, American College of Obstetricians and Gynecologists, American Academy of Pediatrics, Society for Maternal-Fetal Medicine, Centers for Disease Control and Prevention, and the March of Dimes Foundation

US Food and Drug Administration (FDA) Risk Communication Advisory. Committee public comment hearing regarding appropriate labeling of opioid use during pregnancy. Read ACOG’s Statement on Opioid Use During Pregnancy (May 2016)

Visit ACOG’s resource overview page on opioids for additional materials. 



Back to top